Risankizumab (Genetical Recombination) ( DrugBank: Risankizumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-184008	28/8/2018	21/06/2018	A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Ex ...	A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Ex ...	Ulcerative Colitis (UC)	Intervention name : Risankizumab (Genetical Recombination) INN of the intervention : risankizumab Dosa ...	AbbVie GK	NULL	recruiting	16	80	BOTH	70	Phase 3	Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa
2	JPRN-JapicCTI-183997	29/5/2018	12/06/2018	A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy ...	A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy ...	Ulcerative Colitis (UC)	Intervention name : Risankizumab (Genetical Recombination) INN of the intervention : risankizumab Dosa ...	AbbVie GK	NULL	recruiting	16	80	BOTH	65	Phase 2-3	Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa

First Previous1Next Last